Literature DB >> 9810005

von Hippel-Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids.

B Lieubeau-Teillet1, J Rak, S Jothy, O Iliopoulos, W Kaelin, R S Kerbel.   

Abstract

Previous results using gene transfection methods have shown that the wild-type (WT) von Hippel-Lindau (VHL) gene can function as a potent tumor suppressor gene in vivo for renal cell carcinoma (RCC) cells in the absence of any suppressive effect on cell growth in monolayer cell culture under serum-rich conditions. Because we had previously found that the function of some oncogenes, such as mutant ras, can be influenced by three-dimensional growth as multicellular spheroids (J. Rak et aL, J. Cell Biol., 131: 1587-1598, 1995), we reasoned the same might be true for suppressor genes as well. We, therefore, decided to compare and study the effects of the WT VHL gene in monolayer versus three-dimensional culture systems of the RCC cell line 786-0, which contains an inactivated VHL gene. We found that the reintroduction of the WT VHL gene into mutant VHL RCC cells resulted in growth suppression in vitro, but only when the cells were grown as spheroid cultures. This decrease in cell proliferation was associated with several features of cell differentiation/morphogenesis, as shown by light and electron microscopy. Thus, in contrast to cultures of mutant VHL RCC cells, which formed very compact and cohesive spheroids, the WT VHL transfectants were loosely arranged and formed a network of tubular and trabecular structures within the spheroids. The morphological changes of the WT VHL spheroids were associated with the deposition of fibronectin in the extracellular space, a feature that was absent in the mutant and inactivated VHL gene-expressing spheroids. The results suggest the VHL gene may be involved in the maintenance of the epithelial phenotype of renal tubular cells, ie., it may act as a differentiation/morphogenetic factor. Moreover, this effect in tumors cells appears to be highly dependent on multicellular growth conditions that mimic the basic nature of solid tumors, such as RCC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9810005

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Identification of Jade1, a gene encoding a PHD zinc finger protein, in a gene trap mutagenesis screen for genes involved in anteroposterior axis development.

Authors:  Elena Tzouanacou; Susan Tweedie; Valerie Wilson
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

2.  Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer.

Authors:  Aleksandra Franovic; Lakshman Gunaratnam; Karlene Smith; Isabelle Robert; David Patten; Stephen Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-01       Impact factor: 11.205

3.  Clusterin is a secreted marker for a hypoxia-inducible factor-independent function of the von Hippel-Lindau tumor suppressor protein.

Authors:  Eijiro Nakamura; Paula Abreu-e-Lima; Yasuo Awakura; Takahiro Inoue; Toshiyuki Kamoto; Osamu Ogawa; Hirokazu Kotani; Toshiaki Manabe; Guo-Jun Zhang; Keiichi Kondo; Vānia Nosé; William G Kaelin
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

4.  VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling.

Authors:  E J Davidowitz; A R Schoenfeld; R D Burk
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

5.  Jade-1, a candidate renal tumor suppressor that promotes apoptosis.

Authors:  Mina I Zhou; Rebecca L Foy; Vipul C Chitalia; Jin Zhao; Maria V Panchenko; Hongmei Wang; Herbert T Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-26       Impact factor: 11.205

Review 6.  Alterations in VHL as potential biomarkers in renal-cell carcinoma.

Authors:  Lucy Gossage; Tim Eisen
Journal:  Nat Rev Clin Oncol       Date:  2010-04-06       Impact factor: 66.675

7.  VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail.

Authors:  Andrew J Evans; Ryan C Russell; Olga Roche; T Nadine Burry; Jason E Fish; Vinca W K Chow; William Y Kim; Arthy Saravanan; Mindy A Maynard; Michelle L Gervais; Roxana I Sufan; Andrew M Roberts; Leigh A Wilson; Mark Betten; Cindy Vandewalle; Geert Berx; Philip A Marsden; Meredith S Irwin; Bin T Teh; Michael A S Jewett; Michael Ohh
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

8.  Sodium butyrate enhances the growth inhibitory effect of sunitinib in human renal cell carcinoma cells.

Authors:  Hiromi Sato; Miaki Uzu; Tatsuro Kashiba; Rina Suzuki; Takuya Fujiwara; Hiroko Okuzawa; Koichi Ueno
Journal:  Oncol Lett       Date:  2017-05-19       Impact factor: 2.967

9.  Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification.

Authors:  Qiliang Cai; Suhbash C Verma; Pankaj Kumar; Michelle Ma; Erle S Robertson
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

10.  Differences in regulation of tight junctions and cell morphology between VHL mutations from disease subtypes.

Authors:  Valentina Bangiyeva; Ava Rosenbloom; Ashlynn E Alexander; Bella Isanova; Timothy Popko; Alan R Schoenfeld
Journal:  BMC Cancer       Date:  2009-07-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.